Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.51 USD | +0.86% | -3.93% | +2.76% |
May. 02 | UBS Adjusts Price Target on Scotts Miracle-Gro to $74 From $79, Maintains Neutral Rating | MT |
May. 02 | Truist Adjusts Scotts Miracle-Gro's PT to $65 From $75, Keeps Hold Rating | MT |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company has a low valuation given the cash flows generated by its activity.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- One of the major weak points of the company is its financial situation.
- The firm trades with high earnings multiples: 26.68 times its 2024 earnings per share.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.76% | 3.72B | B- | ||
+15.84% | 38.69B | C | ||
-.--% | 11.47B | - | B+ | |
-2.05% | 7.71B | A | ||
+3.38% | 6.63B | B- | ||
-1.21% | 6.32B | B+ | ||
-1.33% | 5.92B | B | ||
-11.01% | 5.59B | - | C- | |
+29.68% | 5.12B | B- | ||
-12.23% | 4.66B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SMG Stock
- Ratings The Scotts Miracle-Gro Company